Western University

Scholarship@Western
Aboriginal Policy Research Consortium International (APRCi)

2004

Characteristics of Aboriginal Injecting Drug Users
in Sydney, Australia: Prison History, Hepatitis C
Status and Drug Treatment Experiences
Carolyn Day
Joanne Ross
Kate Dolan

Follow this and additional works at: https://ir.lib.uwo.ca/aprci
Part of the Criminology and Criminal Justice Commons, Other Public Health Commons, and
the Substance Abuse and Addiction Commons
Citation of this paper:
Day, Carolyn; Ross, Joanne; and Dolan, Kate, "Characteristics of Aboriginal Injecting Drug Users in Sydney, Australia: Prison History,
Hepatitis C Status and Drug Treatment Experiences" (2004). Aboriginal Policy Research Consortium International (APRCi). 408.
https://ir.lib.uwo.ca/aprci/408

This article was downloaded by: [University of Western Ontario]
On: 25 October 2012, At: 13:14
Publisher: Routledge
Informa Ltd Registered in England and Wales Registered Number: 1072954
Registered office: Mortimer House, 37-41 Mortimer Street, London W1T 3JH,
UK

Journal of Ethnicity in
Substance Abuse
Publication details, including instructions for
authors and subscription information:
http://www.tandfonline.com/loi/wesa20

Characteristics of Aboriginal
Injecting Drug Users in Sydney,
Australia: Prison History,
Hepatitis C Status and Drug
Treatment Experiences
a

a

Carolyn Day Bsc (Hons) , Joanne Ross PhD & Kate
Dolan PhD

a

a

National Drug and Alcohol Research Centre,
University of New South Wales, Australia
Version of record first published: 04 Oct 2008.

To cite this article: Carolyn Day Bsc (Hons), Joanne Ross PhD & Kate Dolan PhD
(2004): Characteristics of Aboriginal Injecting Drug Users in Sydney, Australia: Prison
History, Hepatitis C Status and Drug Treatment Experiences, Journal of Ethnicity in
Substance Abuse, 2:3, 51-58
To link to this article: http://dx.doi.org/10.1300/J233v02n03_03

PLEASE SCROLL DOWN FOR ARTICLE
Full terms and conditions of use: http://www.tandfonline.com/page/termsand-conditions
This article may be used for research, teaching, and private study purposes.
Any substantial or systematic reproduction, redistribution, reselling, loan,
sub-licensing, systematic supply, or distribution in any form to anyone is
expressly forbidden.

Downloaded by [University of Western Ontario] at 13:14 25 October 2012

The publisher does not give any warranty express or implied or make any
representation that the contents will be complete or accurate or up to
date. The accuracy of any instructions, formulae, and drug doses should be
independently verified with primary sources. The publisher shall not be liable
for any loss, actions, claims, proceedings, demand, or costs or damages
whatsoever or howsoever caused arising directly or indirectly in connection
with or arising out of the use of this material.

Downloaded by [University of Western Ontario] at 13:14 25 October 2012

Characteristics of Aboriginal
Injecting Drug Users in Sydney, Australia:
Prison History, Hepatitis C Status
and Drug Treatment Experiences
Carolyn Day, Bsc (Hons)
Joanne Ross, PhD
Kate Dolan, PhD

ABSTRACT. Australian Aboriginals are overrepresented in prisons
and tend to be overrepresented in studies of injecting drug users (IDU).
The aim of this study was to examine differences between Aboriginal
and non-Aboriginal IDUs in terms of gender, prison history and hepatitis
C status and testing. Secondary analyses were conducted on data from
three cross-sectional studies of IDUs. These studies employed similar
methodologies, with recruitment being through needle and syringe programs, methadone clinics, snowballing and street intercepts. All studies
were coordinated through the National Drug and Alcohol Research Centre. Aboriginal people were overrepresented in all studies, were more
likely to have been incarcerated and to report heroin as their drug of
choice than non-Aboriginal IDUs. Females tended to be overrepresented
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among Aboriginal IDUs, were more likely to have been incarcerated and
had a longer period of time since their last hepatitis C test than non-Aboriginal female IDUs. Aboriginal people are overrepresented among
IDUs in Sydney. Given their greater risk of incarceration, particularly
among females, Aboriginal IDUs were at greater risk of hepatitis C exposure than non-Aboriginal IDUs. The prison setting provides an opportunity to promote drug treatment and hepatitis C testing, though more
needs to be done to reduce drug use and incarceration. [Article copies
available for a fee from The Haworth Document Delivery Service: 1-800HAWORTH. E-mail address: <docdelivery@haworthpress.com> Website: <http://
www.HaworthPress.com> © 2003 by The Haworth Press, Inc. All rights reserved.]

KEYWORDS. Australian Aboriginals, injecting drug use, prison, drug
treatment and hepatitis C testing

Australian Aboriginals make up approximately 2% of the Australian
population, yet constitute 15% of the national prison population (Australian Bureau of Statistics, 1998, 2002). In New South Wales (NSW)
prisons, 19% of female inmates were of Aboriginal or Torres Strait Islander descent compared to 14% of male inmates (Corben, 2001).
Injecting drug users (IDUs) are also overrepresented in prison populations. A study of prison entrants in the state of Victoria found that
46% of the sample reported a history of injecting drug use, many of
whom injected drugs while in prison (Crofts et al., 1995). The NSW Inmate Health Survey found that 32% of females and 21% of males had
injected drugs in prison at some time (Butler, 1997).
Given the unknown parameters of the IDU population, it is difficult
to know the prevalence of injecting drug use among Aboriginal and
non-Aboriginal groups. The National Drug Strategy Household Survey
found that the prevalence of heroin, cocaine and amphetamine use was
similar among Aboriginal and non-Aboriginal populations (Commonwealth Department of Health and Aged Care, 1994), though household
surveys are likely to underestimate illicit drug use (Hall, Ross, Lynskey,
Law, & Degenhardt, 2000). Furthermore, the extent of injecting drug
use is likely to differ between jurisdictions and communities. One study
reported significantly different levels of lifetime heroin use among Ab-
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original communities living in two small urban communities in NSW
(12% vs. 1%) (Perkins et al., 1994). Aggregated lifetime prevalence of
heroin use for the two communities was higher in the Aboriginal population when compared to the general population (6% and 2%) (Perkins
et al., 1994).
In the National needle and syringe program survey, 5% of the sample
were Aboriginal, further indicating that Aboriginal people are overrepresented among IDU populations (MacDonald et al., 1997). This
trend has been even more evident in Sydney: in the Australian Study of
HIV and Injecting Drug Use, 13% of the Sydney sample were Aboriginal, compared to 5% of the national sample, despite similar recruitment
methods (Loxley, Carruthers, & Bevan, 1995; Rutter, Dolan, & Wodak,
1996).
Despite a burgeoning body of literature on alcohol and other drug problems among Aboriginal people (for a review see Gracey, 1998), a review
of Australian illicit drug research found that there has been little research into Aboriginal injecting drug use (Hando, Hall, Rutter, & Dolan,
1998). With secondary analyses of existing databases, the current study
examined differences between Aboriginal and non-Aboriginal IDUs in
terms of gender, prison history, hepatitis C virus antibody (HCV) testing and drug treatment history.
METHODS
Studies completed by the National Drug and Alcohol Research Centre (NDARC) since 1997, which targeted IDUs and contained information on Aboriginal and Torres Straight Islander status, were selected.
Data for three cross-sectional studies of IDUs recruited in Sydney were
available for review: The Illicit Drug Reporting System (IDRS), the
Australian Prevalence and Estimate of Treatment Study (APET) and
the Australian Blood-borne virus Risk and Injecting Drug Use Study
(ABRIDUS). The IDRS involved a cross-sectional study repeated over
four years (1997-2000). These studies were aggregated into one data
set. APET data were collected from October 2000 to March 2001 and
ABRIDUS data were collected in 1999.
All studies targeted similar populations and used similar entry criteria. Participants were either current IDUs (any drug), heroin users or on
a methadone maintenance program. Aboriginal IDUs were not specifically targeted and participation was voluntary.
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In each study participants were recruited through a variety of methods, including needle and syringe programs and methadone clinics, or
via street intercept and snowballing (word of mouth). Interviews were
conducted face-to-face by trained interviewers using structured questionnaires. Participants were reimbursed $20 or $30 for travel expenses.
All studies collected information on demographics, main drug used,
needle and syringe sharing and prison history. APET and ABRIDUS
collected information on self-reported HCV status and drug treatment
history. APET also collected information on HCV testing.
RESULTS
Aboriginal people were overrepresented in all three studies, constituting 15-19% of the samples (Table 1). Characteristics of Aboriginal
and non-Aboriginal IDU are shown in Table 2. There were more female
Aboriginal IDU than non-Aboriginal IDU in APET (56% vs. 33%, 2 =
12.62, 1 df, p < 0.001).
Lifetime prevalence of incarceration was higher in the Aboriginal
sample than the non-Aboriginal sample in the IDRS (68% vs. 49%, 2 =
13.72, 1 df, p < 0.001).
More Aboriginal IDUs reported heroin as their main drug than
non-Aboriginal IDUs, in APET (87% vs. 76%, 2 = 4.32, 1 df, p < 0.05).
Similar proportions of Aboriginal and non-Aboriginal IDUs reported
using a needle or syringe after another person in the last month. Aboriginal and non-Aboriginal IDUs were similar in all other areas investigated (Table 2).
Female IDUs
There were 441 female IDUs in the three studies, representing 24%
of participants in all studies. More Aboriginal females reported a history of incarceration than non-Aboriginal females in the IDRS (68% vs.
TABLE 1. Percent of Aboriginal IDU in Each Study
Study

Year of Data Collection

n

% Aboriginal

APET

2000-2001

399

17

IDRS

1997-2000

636

19

1999

150

15

ABRIDUS
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TABLE 2. Characteristics of Aboriginal and Non-Aboriginal IDU
Variable
Mean Age (SD)
APET
IDRS
ABRIDUS
% Female
APET*
IDRS
ABRIDUS
% Ever been in prison
APET
IDRS*
ABRIDUS
% Used a syringe after another
person in past month
APET
IDRS
ABRIDUS
% HCV positive (self reported)
APET
ABRIDUS
% Main drug heroin
APET**
IDRS
ABRIDUS
% History of treatment for heroin
dependence
APET
ABRIDUS
% Ever experienced a barrier
to treatment for heroin use
APET

Aboriginal

Non-Aboriginal

33 (6.7)
30 (7.1)
29 (7.9)

31 (8.2)
29 (7.9)
30 (7.8)

59
39
45

33
35
38

54
68
68

39
49
51

7
10
24

9
18
26

59
67

59
64

87
85
77

76
78
69

59
67

59
64

38

40

*p < 0.001, **p < 0.05

49%, 2 = 6.61, 1 df, p < 0.01) and ABRIDUS (68% vs. 51%, Fisher’s
exact test, p < 0.01).
There were no significant differences in terms of self-reported HCV
status between the Aboriginal and non-Aboriginal females or in receiving pre- and post-test counselling. However, Aboriginal females were
significantly more likely to report a longer period of time since their last
HCV test (45 vs. 25 weeks, t137 = 2.58, p < 0.01).
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In APET more Aboriginal females reported heroin as their main drug
compared to non-Aboriginal females (90% vs. 72%, Fisher’s exact test, p <
.05). Similar proportions of Aboriginal and non-Aboriginal females reported ever having been in drug treatment in both APET (82% and 87%,
respectively) and ABRIDUS (80% and 56%).
DISCUSSION
To date there has been little research into injecting drug use among
Aboriginal people and little is currently known about this group (Hando
et al., 1998). This study, however, has found that Aboriginal people
were overrepresented among samples of IDUs in Sydney. Compared to
non-Aboriginal IDUs, Aboriginal IDUs were more likely to have been
imprisoned. The study has also found that Aboriginal females were overrepresented in samples of IDUs relative to non-Aboriginal females, and
that these Aboriginal females were significantly more likely to have a
history of incarceration. Both of these factors suggest that Aboriginal
IDUs and their communities are at a double disadvantage in terms of
blood-borne viral risk.
The overrepresentation of Aboriginal people in Australian prisons
has been well documented, as has the overrepresentation of IDUs (Butler et al., 1997; Crofts et al., 1995; Royal Commission into Aboriginal
Deaths in Custody, 1991). The prevalence of HCV among Australian prisoners is also high (Butler et al., 1997; Crofts et al., 1995) and despite
limited research, transmission is also likely to be high (Dolan, 2001).
Aboriginal people who inject drugs were more likely to report a history
of incarceration than their non-Aboriginal peers, placing them and their
communities at higher risk of blood-borne viral infections than other
IDUs.
Some reasons given for the elevated levels of incarceration of Aboriginal people generally include issues around racism, colonisation,
and the dispossession of land and culture oppression (Lincoln & Wilson, 1994). The added problems of dependency and the pressure and
stigma of illicit drug use may further compound the problem.
Females typically account for approximately a third of the IDU population (Loxley et al., 1995; MacDonald et al., 1997). Yet, this study
found that Aboriginal females constitute closer to 50% of Aboriginal
IDUs and that they were more likely to have been incarcerated than
non-Aboriginal female IDUs. Females who inject drugs are disadvantaged in a range of areas, including syringe sharing and treatment op-

Downloaded by [University of Western Ontario] at 13:14 25 October 2012

Day, Ross, and Dolan

57

tions (Whynot, 1998). The prevalence of HCV is also higher among
female prisoners compared to male prisoners (Butler et al., 1997; Crofts
et al., 1995). These three factors taken together indicate greater HCV
risk for Aboriginal female IDUs compared to non-Aboriginal female
IDUs.
Aboriginal females were less likely to have reported being recently
tested for HCV than the non-Aboriginal females, indicating that HCV
may be higher than reported. As demonstrated with HIV, pre- and
post-test counselling can reduce risk behaviour (Gibson, McCusker, &
Chesney, 1998). That large proportions of IDUs had not received counselling (or do not remember anything of the process) is of concern and
has implications in terms of the prevention of blood-borne viral transmission and requires further investigation.
There are a number of limitations of this study. The data presented
here were from three different studies with different aims and therefore
instruments. However, all three studies were conducted by the same
Centre and similar methodologies were employed. The small numbers
of participants in each study may have compromised statistical power
and therefore the number of firm conclusions that can be made.
Nonetheless, the data from this study have suggested that Aboriginal
people were overrepresented among IDUs, particularly females, and are
therefore at increased risk of HCV and other blood-borne infections.
Given the high prevalence of incarceration reported by Aboriginal
IDUs, the prison setting provides an opportunity to promote drug treatment and blood-borne virus testing. However, more needs to be done to
reduce the numbers of both Aboriginal people and IDUs entering prison.
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